<DOC>
	<DOCNO>NCT01203098</DOCNO>
	<brief_summary>The objective study compare efficacy , safety DU-176b 30mg DU-176b 15mg versus enoxaparin sodium prevention venous thromboembolism patient elective total hip arthroplasty .</brief_summary>
	<brief_title>A Phase 2b Study DU-176b , Prevention Venous Thromboembolism Patients After Total Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Embolism Thrombosis</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>1 . Patients undergo unilateral total hip arthroplasty 2 . Patients 2084 year olds 1 . Subjects risks hemorrhage 2 . Subjects thromboembolic risk 3 . Subjects weigh less 40 kg 4 . Subjects pregnant suspect pregnancy , subject want become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>prevention</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>edoxaban</keyword>
	<keyword>anticoagulant</keyword>
</DOC>